Clinical Trial Detail

NCT ID NCT03228537
Title Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

malignant pleural mesothelioma

Therapies

Atezolizumab + Cisplatin + Pemetrexed Disodium

Age Groups: adult senior

No variant requirements are available.